HomeSUPN • NASDAQ
add
Supernus Pharmaceuticals Inc
Previous close
$35.82
Day range
$35.85 - $36.66
Year range
$25.53 - $38.79
Market cap
2.00B USD
Avg Volume
367.01K
P/E ratio
33.91
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 175.69M | 14.17% |
Operating expense | 129.78M | 2.51% |
Net income | 38.50M | 340.97% |
Net profit margin | 21.91 | 311.08% |
Earnings per share | 1.10 | 354.27% |
EBITDA | 48.43M | 63.96% |
Effective tax rate | 14.34% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 403.21M | 101.41% |
Total assets | 1.34B | 4.48% |
Total liabilities | 335.55M | -10.03% |
Total equity | 1.01B | — |
Shares outstanding | 55.22M | — |
Price to book | 1.96 | — |
Return on assets | 5.33% | — |
Return on capital | 6.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 38.50M | 340.97% |
Cash from operations | 53.52M | 49.18% |
Cash from investing | -77.01M | -322.36% |
Cash from financing | 3.08M | 1,436.96% |
Net change in cash | -20.42M | -129.05% |
Free cash flow | 35.61M | -61.13% |
About
Founded
2005
Headquarters
Website
Employees
652
